Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)

KEY POINTS Cellular immunotherapy is a novel therapy where the body’s own immune cells are harnessed for their anticancer effect. One of the most exciting of these approaches is chimeric antigen receptor T-cell therapy (CAR-T). This therapy is now standard of care for relapsed or refractory B-cell